Categories AlphaGraphs, Earnings, Health Care

Veru Inc. (VERU): Q1 2021 Earnings Snapshot

Veru Inc. (NASDAQ: VERU) reported its financial results for the second quarter ended March 31, 2021, on Wednesday before the market opens.

The company had net revenue of $13.3 million with an increase of 34%.

Veru Inc suffered a net loss of $2.8 million or $0.04 loss per share compared to the loss of $0.8 million or $0.01 loss per share of the same quarter in the previous year.

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Viewing Highlight